Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
Age bias in oncology can lead to younger patients receiving more aggressive treatments with marginal survival benefits, potentially compromising their quality of life.
Hematology/Oncology August 12th 2024
Cleveland Clinic Journal of Medicine
Early targeted palliative care consultations in the ICU can significantly increase transitions to do-not-resuscitate orders and reduce the duration of mechanical ventilation, enhancing end-of-life care.
Family Medicine/General Practice May 22nd 2024
For healthcare professionals managing terminal patients, understanding the logistics and safety of international end-of-life travel is crucial, including medication management and legal documentation.
All Specialties May 13th 2024
The New England Journal of Medicine
Discover the nuanced skills required in communicating with patients facing serious illnesses. The article emphasizes the importance of not just conveying information, but also supporting patients through the emotional and cognitive aspects of their prognosis.
All Specialties January 10th 2024
Psychiatrist.com
There is plenty of psychological material that can be examined in the palliative care encounter, despite the fact that it is frequently practiced by doctors with backgrounds outside of mental health training. This case presentation and associated discussion to introduce the psychological aspects of palliative medicine to psychiatrists and psychotherapists is based on the palliative care consultation sought with the multiple objectives of alleviating a patient’s severe death anxiety and persistent dyspnea, as well as helping in the clarification of his end-of-life wishes.
Geriatrics August 22nd 2022
JAMA Network
Publication: JAMADesign: Multicenter, randomized, double-blind, placebo-controlled trial performed in six hospices in the Netherlands of 162 patients with a life expectancy of three or more days. Administration of subcutaneous scopolamine butylbromide, 20 mg four times a day (n = 79) or placebo (n=78) in the 157 patients included in the primary analysis.Results: A death rattle occurred in 10 patients (13%) in the scopolamine group compared with 21 patients (27%) in the placebo group.
Cardiology October 12th 2021